Page last updated: 2024-08-23

atomoxetine hydrochloride and Ambulation Disorders, Neurologic

atomoxetine hydrochloride has been researched along with Ambulation Disorders, Neurologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jankovic, J1

Trials

1 trial(s) available for atomoxetine hydrochloride and Ambulation Disorders, Neurologic

ArticleYear
Atomoxetine for freezing of gait in Parkinson disease.
    Journal of the neurological sciences, 2009, Sep-15, Volume: 284, Issue:1-2

    Topics: Adrenergic Uptake Inhibitors; Aged; Antiparkinson Agents; Atomoxetine Hydrochloride; Double-Blind Method; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Propylamines; Severity of Illness Index

2009